delorenzoferruccio.jpg Ferruccio De Lorenzo
Columnista Experta de SIIC


MD, PhD, CCST, Consultant Physician, Thrombosis Research Institute, Londres, Reino Unido
ANTICOAGULACION EN PACIENTES CON INSUFICIENCIA CARDIACA
Columnista Experta de SIIC Ferruccio De Lorenzo en colaboración con Olena Dotsenko , MD, Thrombosis Research Insitute


Fecha de aprobación: 23 de junio, 2005
Primera edición en siicsalud: 27 de febrero, 2006
Sección Artículos originales, subsección Expertos de Iberoamérica,
página /des/expertocompleto.php/74820  
Especialidad principal: Especialidad principalCardiología
Especialidad principalHematología

Especialidades relacionadas:
Medicina Farmacéutica,Medicina Interna,

  • De Lorenzo F, Xiao H, Kadziola Z, Scully M, Kakkar VV. Risk of recurrent thrombotic events in patients with coronary heart disease and left ventricular dysfunction, Int J Cardiol 89(89):93-93, 2003

  • De Lorenzo F, Xiao H, Scully M, Kadziola Z, Kakkar VV. Pre-thrombotic state and impaired fibrinolytic potential in CHD patients with left ventricular dysfunciton, Blood Coagulation & Fibrinolysis 14:67-75, 2003

  • De Lorenzo F, Saba N, Dancy M, Kadziola Z, Kakkar VV, Xiao HB. Induced ischemia detected by dobutamine stress echocardiogrphy in CHD patients after myocardial re-vascularization. Experience in a Disctrict General Hospital, Int J Cardiol 83(83):119-124, 2002

  • De Lorenzo F, Newberry D, Scully M, Kadziola Z, Dawson G, Ranlall N, Saba N, Noorani A, Kashani S, Williams R, Kakkar VV. Low molecular weight heparin (LMWH) (Bemiparin Sodium 3,500 IU) on the regulation profile of patients with hearth failure, Am Heart J 143(143):689, 2002

  • Kakkar VV, Iyengar SS, De Lorenzo F, Hargreaves JR, Kadziola ZA; on behalf of the FAMI Investigator Group. Low-molecular wigth heparin for treatment of acute myocardial infarction FAMI: Fragmin (Dalteparin Sodium) in acute myocardial infarction, Indian Heart Journal 52(52):533-539, 2002

  • De Lorenzo F, Xiao H, Kakkar VV. Prognostic role of plasminogen-activator-inhibitor-1 (PAI-1) levels in treatment with streptokinase of patients with acute myocardial infarction, Clin Cardiol 23:877-878, 2000


  • Ferruccio De Lorenzo

    ua40317